Inhibitor Therapeutics, Inc. Current Liabilities
Inhibitor Therapeutics, Inc. (INTI) had Current Liabilities of $174.89 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $174.89K.
- 2026-03-31: Liabilities, Current $382.32K.
- 2025-12-31: Liabilities, Current $766.33K.
- 2025-09-30: Liabilities, Current $87.53K.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $174.89K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $382.32K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $766.33K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $87.53K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $139.96K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $94.71K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $709.62K 10-K · filed 2026-03-26 |
| 2024-09-30 | $44.56K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $35.53K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $155.85K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $665.16K 10-K · filed 2025-03-28 |
| 2023-09-30 | $156.44K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $43.86K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $78.44K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $678.78K 10-K · filed 2024-03-29 |
| 2022-09-30 | $1.09M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $935.02K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $830.21K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $679.63K 10-K · filed 2023-03-31 |
| 2021-09-30 | $590.89K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $554.86K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $432.61K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $425.41K 10-K · filed 2022-03-30 |
| 2020-09-30 | $458.52K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $461.58K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $345.90K 10-Q · filed 2020-05-01 |
| 2019-12-31 | $431.10K 10-K · filed 2021-03-26 |
| 2019-09-30 | $358.93K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $304.77K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $324.82K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $700.65K 10-K · filed 2020-03-30 |
| 2018-09-30 | $549.08K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $461.89K 10-Q · filed 2018-07-23 |
| 2018-03-31 | $441.16K 10-Q · filed 2018-05-01 |
| 2017-12-31 | $601.49K 10-K · filed 2019-03-07 |
| 2017-09-30 | $252.20K 10-Q · filed 2017-10-31 |
| 2017-06-30 | $339.58K 10-Q · filed 2017-07-31 |
| 2017-03-31 | $395.81K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $308.13K 10-K · filed 2018-02-16 |
| 2016-09-30 | $469.60K 10-Q · filed 2016-10-31 |
| 2016-06-30 | $618.07K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $743.43K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $461.88K 10-K · filed 2017-02-17 |
| 2015-09-30 | $540.41K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $412.69K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $568.57K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $400.90K 10-K · filed 2016-02-01 |
| 2014-09-30 | $432.65K 10-Q · filed 2014-10-10 |
| 2014-06-30 | $453.87K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $972.78K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $776.05K 10-K · filed 2015-02-13 |
| 2013-09-30 | $550.78K 10-Q · filed 2013-11-14 |
| 2012-12-31 | $559.95K 10-K · filed 2014-04-15 |